Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: The story does not talk about costs, which was disappointing. The costs of intensive medical therapy can easily be identified. Using an online pharmacy we calculated the costs to be about $1,500 to $2,000 annually for medical therapy, using generic drugs. Using the Health Care Blue Book, we found the average cost of coronary artery bypass sugery and hospitalization to be about $62,000. We think that this is important information for readers that should have been included. The quantification here was presented in such a way to make it clear to readers that there was no significant benefit found to surgical intervention, which is a fair conclusion to draw from the study. The story says, “In the Stich study, 41% of patients assigned to treatment with drugs alone died during the follow-up period, which averaged five years. That compared with a mortality rate of 36% among patients who received bypass surgery plus medication. Although the relative reduction in risk of death was 14%, the result didn’t meet tests for statistical significance, meaning it could have resulted from chance alone.” That’s a great way to describe the lack of statistical significance. It would have been even more powerful to show readers the actual number of patients who died in each group. The story provides great information about the study itself and about the overall state of the evidence supporting heart surgery. “How best to treat these patients has been fraught with uncertainty,” is one of the more notable phrases from the story. It also says, “Many patients aren’t evaluated for heart surgery to treat diseased arteries because they don’t suffer classic chest pain or because doctors worry that hearts weakened by heart failure won’t benefit from the procedure. Other doctors recommend immediate bypass surgery despite a lack of vigorous studies to support that strategy.” The story does not engage in disease-mongering and takes a very careful approach to describing the types of patients who would be affected by this study’s results. We also like the way they provided snapshots of patients who were in both arms of the study — surgery and non-surgery — at the end of the story, making it clear, as the study did, that both routes can be equally successful. The story brings in some strong independent voices who help make sense of this complicated study: James Fang, a cardiologist at University Hospitals Case Medical Center in Cleveland, who wrote an editorial accompanying the study, Raymond Gibbons, a cardiologist at the Mayo Clinic, and Clyde Yancy, chief of cardiology at Northwestern University’s Feinberg School of Medicine. Rarely do you see a story that spends as much time with independent experts as it does with the authors of the study. The story does a great job showing how the standard interventions for heart disease stacked up against each other in this study. We wish that some mention had been made of diet and exercise and that at least a sentence had been included about whether there might be differences in outcomes seen as a result of different medication patterns. The story doesn’t make it clear what exactly the patients were taking. The story makes it clear that the range of treatments studied by the authors are widely available. The story makes it clear that there is a great need for more evidence in this field and that this study will be surprising to many clinicians because of a long-held assumption that surgery is the superior option. tudies published in the early 1990s supported the view that bypass surgery provided a better long term outcome. The story does not rely on a news release.

Output: More Options Before Bypass Surgery, Study Finds


Input: Consider Input: The Council of State ruled that doctors had the right to end the medical support that has kept Vincent Lambert, brain-damaged and in vegetative state, artificially alive since a motorbike accident on the way to work plunged him into a coma in September 2008. The verdict follows a heart-rending battle between Lambert’s  wife Rachel, seeking to let the former psychiatric nurse die, and his parents, who took legal action last year to halt plans by his doctors to do that. Apart from places such as Belgium, the Netherlands and Switzerland, few countries in the world explicitly permit euthanasia or assisted suicide - sometimes known as mercy killings. But France, where President Francois Hollande promised prior to his 2012 election to introduce new right-to-die legislation, has left grey areas regarding more passive forms of euthanasia in a 2005 law on patient rights and care for the terminally ill. The so-called Leonetti law does not legalize euthanasia but also states, according to government information services, that patient treatment should not involve “excessive obstination”. Lambert’s parents, devoutly religious Catholics, said even  before the Council of State’s Tuesday ruling that they had asked the European Court of Human Rights to issue an emergency ruling on the case should the French judges go against their will to keep their son, now in his late 30s, as he is. The international rights court, based in the eastern French city of Strasbourg, said in a statement it would respond “as soon as possible”. While Hollande has yet to deliver on his promise of legislation by the end of the year on the rights of the incurably ill, the legal battles over Lambert’s fate and other cases has thrust the euthanasia debate firmly back onto the radar screen. As many as 25,000 people die a year in France after removal of medical support, according to Remi Keller, a member of the Council of State. In a separate case, a hospital doctor in southwest France is on trial on charges that he used lethal injections to hasten the deaths of seven old-aged people in 2010-2011. His lawyers say they intend to turn that trial into a debate about the wider issue of the boundaries of euthanasia.

Output: France reopens euthanasia debate with right-to-die ruling.


Input: Consider Input: Cobalt is a key ingredient in the batteries that power electric vehicles, a fast-growing sector of the auto industry, and in metal alloys used to make jet engines. It was singled out in LME proposals to embed responsible sourcing principles into metal brands deliverable against its contracts, which include copper and zinc. Most of the world’s supply comes from the Democratic Republic of Congo, often from artisanal mines where several organizations have cited human rights abuses. The LME plan outlined last October involves suspending cobalt brands trading at a significant discount to its contract on the grounds that they may be seen as tainted. Now, objections by NGOs to a consultation on its plans could leave the exchange at risk of legal challenges from banned cobalt producers, metal industry sources say. The LME will publish its proposals this quarter. “The LME received 39 responses to its recent discussion paper on responsible sourcing,” the exchange said. “The LME’s role is now to identify a path forwards which balances the diverse views of its stakeholders (including civil society organizations), while achieving the LME’s stated aim of helping the broader metals industry embrace key principles of responsible sourcing and environmental stewardship.”  The letter from the NGOs said the LME should not immediately ban cobalt brands and that it should work with firms that produce them to ensure responsible sourcing. “It is short-sighted and irresponsible of the LME to single out cobalt and tin as higher risk metals above others, or to single out (artisanal) material as implicitly higher risk,” the letter signed by 14 non-governmental organizations (NGOs) said. All companies involved with the exchange should implement responsible sourcing practices in line with the OECD Guidance, the letter dated Dec. 3 said. The OECD Guidance says companies should report in detail about their supply chains and advises on ways in which they can uncover and address human rights and corruption issues. “Heightened supply chain due diligence on cobalt, as with all other LME metals, must be triggered by assessment of all supply chain risks, including corruption risks,” the NGO letter said. Sources say the business of an exchange is to facilitate trade between buyers and sellers. “The NGOs don’t understand the difference between end consumers and the LME. The LME is a market of last resort, you can’t choose which metal to take or reject,” a metal trading source said. “Consumers can choose where they source their cobalt from, people buying on the LME can’t, that’s why there is such a deep discount between LME cobalt prices and (Fastmarkets MB)”  Cobalt prices published by Fastmarkets MB at around $44,000 a tonne are $12,000 a tonne higher than those for the LME’s contract, which was launched in 2010. However, the NGOs say singling out low-priced cobalt typically produced by artisanal miners ignores other “serious red flags” such as corruption by large-scale miners of all metals. “Is the LME trying to create a reputational green wash that allows it to say its members source responsibly because they tick some boxes,” said Sophie Pickles, who leads Global Witness’ work on conflict mineral. The director of “mines to market” at NGO Pact, Karen Hayes, said the LME’s plan lacked detail on implementation. “We are more than willing to work with the LME or any companies seeking to comply with the LME’s responsible sourcing standards,” she said.


Output: Fourteen NGOs oppose London Metal Exchange plans to ban tainted cobalt.